Final-Program-ATS-2023-AP.vp

320

WEDNESDAY • MAY 24

117 Development and Validation of a Metabolomic Pipeline to Identify Novel Diagnostic and Therapeutic Targets in Antibiotic Resistant Bacterial Infections/ J.R. Mayers, Boston, MA 118 Plasma Interleukin-6 Concentrations Demonstrate Genetic Regulation Without Causal Effect on Mortality/ T.K. Jones, Philadelphia, PA 119 A New Model for Diagnosing Sepsis-induced Disseminated Intravascular Coagulation (DIC) in Patients With Coagulopathy of Liver Disease—Moving Away From Factor VIII (FVIII) and International Society on Thrombosis and Hemostasis (ISTH) DIC Scores/ C. Allen, New Haven, CT 120 Characterization of the Gastric Microbiome in Sepsis Within a Randomized Clinical Trial of Early Enteral Nutrients/ S. Nath, Pittsburgh, PA 121 Fluid Restriction Vs Higher Volume Resuscitation in Patients With Septic Shock: An Updated Systematic Review and Meta-analysis/ N. Wacher, Fort Lauderdale, FL 122 Variation in Hospital Patterns of Early Testing for Sepsis-associated DIC/ B. Pang, Boston, MA 123 Latent Class Phenotypes Predict Therapeutic Response to Acetaminophen in Sepsis Patients With Elevated Cell-Free Hemoglobin: A Reanalysis of the Across Trial/ L.B. Ware, Nashville, TN 124 Diagnostic Performance of Monocyte Distribution Width

1002 Characteristics of Adults With a History of Severe Childhood Asthma - A Cohort Study With a 60-year Follow-up/ O. Savran, Hvidovre, Denmark 1003 Analysis of Hospitalization Outcomes in Patients With Asthma-COPD Overlap Syndrome/ M. Modak, Oklahoma City, OK 1004 Airway Tree Caliber and Progression of Emphysema in MESA Air and Lung Study/ C. Sack, Seattle, WA 1005 Association of Airway Tree Caliber With Serum Interleukin-6 Among Older Adults: The Multi-ethnic Study of Atherosclerosis (MESA) Lung Study/ C.G. Murphy, New York, NY 1006 The Association of Long-term PM2.5 Exposure and Racial Disparities in Mortality in COPD/ C. Robichaux, Minneapolis, MN 1007 Association of Mucus Hydration and Indoor Air Pollution With Mucociliary Clearance in Individuals With COPD/ L.M. Paulin, Lebanon, NH 1008 Air Pollution May Increase Respiratory Viral Infection in Patients With Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease/ K.H. Min, Seoul, Korea, Republic of 1009 Profiles of Exposure to Air Pollution From Multiple Sources and Respiratory Outcomes in Middle Age/ D.S. Bui, Melbourne, Australia 1010 Vitamin D Status Modifies the Association of Indoor Particulate Matter With Morbidity in Obese Adults With Chronic Obstructive Pulmonary Disease/ W. Lorizio, Baltimore, MD 1011 The Contribution of Social and Environmental Factors for Lung Function Decline in Chronic Obstructive Pulmonary Disease: Longitudinal Analysis of Electronic Medical Records Data/ G.R. Oates, Birmingham, AL 1012 Measuring Disparities in Virtual Healthcare and Outcomes in Chronic Obstructive Pulmonary Disease Patients During the COVID-19 Pandemic/ M.R. Cherabuddi, Detroit, MI 1013 Sex, Tobacco, and Chronic Obstructive Pulmonary Disease: Multivariable Analysis of Two Large National Datasets/ A. Steinberg, Lebanon, NH 1014 Sex-related Differences, Mortality and FEV1 Decline Among COPD Patients: The French Palomb Cohort/ N. Jestin-Guyon, Bordeaux, France 1015 Rare Alpha-1 Antitrypsin Deficiency Variants Detected in Ireland/ T.P. Carroll, Dublin, Ireland

for Early Sepsis Detection in the Hospital Setting: A Systematic Review and Meta-analysis/ G.J. Eisinger, Columbus, OH

BEHAVIORAL • CLINICAL POSTER DISCUSSION SESSION

D26

RISK FACTORS FOR COPD AND LUNG CANCER: BEYOND TOBACCO

8:00 a.m. - 10:00 a.m.

Marriott Marquis Washington Marquis Ballroom, Salons 9-10 (Level M2)

Poster Viewing

8:00-8:45 8:45-10:00

Discussion

Chairing: S. Raju, MD, MPH, Baltimore, MD C. Sack, MD, MPH, Seattle, WA 1001 Risk of Hospitalization Due to Lung Cancer Among Smokers Not Recommended for Annual LDCT Screening by the 2021 USPSTF Guidelines/ J.A. Nations, Washington, DC

ATS 2023 • Washington, DC